Back to Medicines

Glipizide: A Shorter-Acting Sulfonylurea

Glipizide: A Shorter-Acting Sulfonylurea
Prescription Medicines Editorial 22 August 2025

Glipizide is a sulfonylurea. It binds to receptors on the insulin-producing cells of the pancreas and makes them release insulin regardless of what blood glucose is doing - which is what separates the class from metformin, the gliptins and the SGLT2 inhibitors, none of which cause hypoglycaemia on their own. Glipizide's distinguishing feature within the group is that it works quickly and clears quickly, which limits one of the class's main problems.

Follow the instructions on your label. This guide contains no doses.

Take it before food

Glipizide is absorbed rapidly, and taking it about half an hour before a meal times the insulin release to the food arriving.

Taken with or after food, the peak arrives late and does less for the post-meal glucose rise.

That is a real difference from gliclazide and glimepiride, which are taken with the first meal.

The meal is not optional. If you are going to miss one, that is a reason to ask what to do rather than simply swallowing it anyway.

Shorter action, shorter hypos

Sulfonylurea hypoglycaemia can be prolonged, lasting many hours and sometimes recurring after apparent recovery - which is why severe episodes usually need hospital observation rather than a biscuit.

Glipizide's shorter duration reduces that tendency compared with longer-acting members of the class, which is one reason it is sometimes preferred in older people.

It does not remove the risk. Hypos still happen, particularly with missed meals, unexpected exercise, alcohol, and in kidney or liver impairment.

See glimepiride and gliclazide and the sulfonylureas.

Recognising and treating a hypo

Sweating, trembling, hunger, palpitations, anxiety and tingling lips, progressing to confusion, slurred speech and difficulty concentrating.

Treat immediately with fast-acting carbohydrate - glucose tablets or a sugary drink - then follow with longer-acting carbohydrate such as a sandwich, because the insulin effect outlasts the sugar.

Carry treatment. Tell the people around you what to look for.

Seek medical help after any severe hypo - one needing another person's help - because of the risk of recurrence.

Beta blockers mask the early warning signs - see metoprolol.

Driving

DVLA rules apply to people taking sulfonylureas, not only to those on insulin.

Check glucose before driving and at intervals on long journeys, keep fast-acting carbohydrate within reach, and do not drive below the threshold. After a hypo, wait until you have fully recovered.

Severe hypoglycaemia requiring another person's help must be reported to the DVLA - see medicines and driving.

If you drive for a living, tell your team - it affects which medicines are appropriate.

Alcohol and fasting

Alcohol suppresses the liver's release of glucose, so it can cause hypoglycaemia several hours later, often overnight - and it masks the symptoms.

Eat carbohydrate when drinking - see medicines and alcohol.

Fasting - for religious observance, a blood test or a procedure - needs planning, and sulfonylureas are frequently the medicine that needs adjusting. If you fast during Ramadan, ask for a review beforehand.

Weight

Sulfonylureas cause weight gain, typically a few kilograms, because insulin promotes storage.

That is a real disadvantage against the newer agents which are weight-neutral or cause weight loss - see sitagliptin and medicines and your weight.

Where sulfonylureas still fit

They are cheap, they work quickly, and they lower glucose effectively - which matters where cost is a constraint, where someone is very symptomatic and needs rapid improvement, or where newer agents are unsuitable.

Their drawback is that the effect wanes over years as pancreatic cells tire, so control drifts and further treatment is needed.

Gliclazide is the sulfonylurea most used in the UK and is generally preferred in older people and in kidney impairment.

Sick days

Unlike metformin and SGLT2 inhibitors, a sulfonylurea is not automatically stopped when you are unwell - illness raises glucose. But if you are not eating, the hypo risk rises sharply.

Ask for sick day rules covering your specific combination - see sick day rules.

Other points

Glipizide is a sulfonamide derivative, so mention any sulfonamide allergy.

Doses are reduced in kidney and liver impairment. Some medicines increase the hypo risk further, including certain antibiotics, fibrates and warfarin - see warfarin.

Rash and photosensitivity occur - see medicines that make you sun-sensitive.

Modified-release forms

Glipizide is available as standard tablets and, in some countries, as a modified-release form taken once daily with breakfast.

The two are not interchangeable, and modified-release tablets must be swallowed whole. The once-daily form removes the before-meals timing requirement, which suits people who eat irregularly - see cutting and crushing tablets.

Is it still needed?

Diabetes treatment accumulates over years and is rarely reviewed downwards. In an older or frailer person, an HbA1c well below target on a sulfonylurea is a reason to reduce rather than a success.

See deprescribing.

More on how the main families of medicine work in the Medicines section, including Diabetes Tablets Beyond Metformin: A Guide.